| Dr Tharun Karthikeyan, MD | |
|
700 Bob-o-link Drive, Lexington, KY 40504 | |
| (859) 258-8575 | |
| (859) 258-8562 |
| Full Name | Dr Tharun Karthikeyan |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 19 Years |
| Location | 700 Bob-o-link Drive, Lexington, Kentucky |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922200468 | NPI | - | NPPES |
| NC1379 | Medicaid | SC | |
| 5917533 | Medicaid | NC |
| Facility Name | Location | Facility Type |
|---|---|---|
| Vna Health At Home | Lexington, KY | Home health agency |
| Lifeline Health Care Of Pulaski | Somerset, KY | Home health agency |
| Saint Joseph Hospital | Lexington, KY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Pt Pros, Inc | 0143139337 | 112 |
| Kentucky Orthopedic Rehabilitation Llc | 0345157293 | 683 |
| New Lexington Clinic, Psc | 3476457532 | 310 |
| H2 Rehabilitation Services Of Kentucky, Llc | 5799682688 | 68 |
News Archive
"A federal subsidy designed to make health insurance more affordable for laid-off workers has led to a doubling in the number of people who have opted to continue their former employer's coverage," USA Today reports. The subsidy, created by the federal stimulus package, covers 65 percent of COBRA premiums for workers who were laid off between Sept. 1, 2008 and the end of this year.
American Society of Anesthesiologists (ASA) Global Humanitarian Outreach (GHO) volunteer Megan Olejniczak, M.D., will travel to Rwanda on Monday, October 19, to participate in a teaching program at the two teaching hospitals of the National University of Rwanda in the cities of Kigali and Butare.
Bruker Corporation today reported financial results for the first quarter ended March 31, 2010.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
Teva Pharmaceutical Industries Ltd. announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $1 billion of its ordinary shares/ADRs over the next 12 months.
› Verified 7 days ago
| Entity Name | New Lexington Clinic Psc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700803681 PECOS PAC ID: 3476457532 Enrollment ID: O20031121000103 |
News Archive
"A federal subsidy designed to make health insurance more affordable for laid-off workers has led to a doubling in the number of people who have opted to continue their former employer's coverage," USA Today reports. The subsidy, created by the federal stimulus package, covers 65 percent of COBRA premiums for workers who were laid off between Sept. 1, 2008 and the end of this year.
American Society of Anesthesiologists (ASA) Global Humanitarian Outreach (GHO) volunteer Megan Olejniczak, M.D., will travel to Rwanda on Monday, October 19, to participate in a teaching program at the two teaching hospitals of the National University of Rwanda in the cities of Kigali and Butare.
Bruker Corporation today reported financial results for the first quarter ended March 31, 2010.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
Teva Pharmaceutical Industries Ltd. announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $1 billion of its ordinary shares/ADRs over the next 12 months.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Tharun Karthikeyan, MD 700 Bob-o-link Drive, Lexington, KY 40504 Ph: (859) 258-8575 | Dr Tharun Karthikeyan, MD 700 Bob-o-link Drive, Lexington, KY 40504 Ph: (859) 258-8575 |
News Archive
"A federal subsidy designed to make health insurance more affordable for laid-off workers has led to a doubling in the number of people who have opted to continue their former employer's coverage," USA Today reports. The subsidy, created by the federal stimulus package, covers 65 percent of COBRA premiums for workers who were laid off between Sept. 1, 2008 and the end of this year.
American Society of Anesthesiologists (ASA) Global Humanitarian Outreach (GHO) volunteer Megan Olejniczak, M.D., will travel to Rwanda on Monday, October 19, to participate in a teaching program at the two teaching hospitals of the National University of Rwanda in the cities of Kigali and Butare.
Bruker Corporation today reported financial results for the first quarter ended March 31, 2010.
VION PHARMACEUTICALS, INC. announced today that it had filed a Special Protocol Assessment (SPA) with the U.S. Food and Drug Administration (FDA) related to a randomized Phase II/III trial of its oncology therapeutic Onrigin™ (laromustine) Injection in combination with low-dose Ara-C (LDAC) in elderly patients with newly diagnosed acute myeloid leukemia (AML). The primary objective for the Phase III part of this study is to determine if Onrigin™ plus LDAC improves overall survival compared with LDAC alone.
Teva Pharmaceutical Industries Ltd. announced today that its Board of Directors has authorized the Company to repurchase (including through one or more subsidiaries) up to an aggregate of $1 billion of its ordinary shares/ADRs over the next 12 months.
› Verified 7 days ago
Graysen Robert Petersen-fitts, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3480 Yorkshire Medical Park, Lexington, KY 40509 Phone: 859-263-5140 Fax: 859-263-5141 | |
Cody Stover, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 700 Bob O Link Dr, Lexington, KY 40504 Phone: 859-258-8575 Fax: 859-258-8562 | |
Dr. Eric Schafer, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3480 Yorkshire Medical Park, Lexington, KY 40509 Phone: 859-263-5140 Fax: 859-263-5141 | |
Peter William Hester, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 700 Bob O Link Dr, Lexington, KY 40504 Phone: 859-258-8576 Fax: 859-258-8562 | |
Veronica A Vasicek, MD Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 3480 Yorkshire Medical Park, Lexington, KY 40508 Phone: 859-263-5140 Fax: 859-263-5141 | |
Jerold N Friesen, MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 125 E Maxwell St, Ste 200, Lexington, KY 40508 Phone: 859-253-0124 Fax: 859-231-8667 | |
Anthony Zacharias, Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: University Of Kentucky, 800 Rose St., Lexington, KY 40536 Phone: 859-218-3044 |